Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Interest & Investment Income came in at $297000.0 in Q1 2026, down 7.76% YoY from $322000.0 in Q1 2025, and down 30.44% on a QoQ basis from $427000.0 in Q4 2025.
Achieve Life Sciences (ACHV) Interest & Investment Income (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Interest & Investment Income data on file, last reported at $297000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 7.76% year-over-year to $297000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 36.36% YoY) and the FY2025 annual result came in at $1.5 million, down 36.54% from the prior year.
- Interest & Investment Income slipped to $297000.0 in Q1 2026, from $427000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $833000.0 in Q2 2024 to a low of $4000.0 in Q1 2022.
- A 5-year average of $304235.3 and a median of $262000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 4725.0% — and 2025, when it plunged 76.95%.
- Tracing ACHV's Interest & Investment Income over 5 years: stood at $118000.0 in 2022, then jumped by 76.27% to $208000.0 in 2023, then jumped by 131.73% to $482000.0 in 2024, then slipped by 11.41% to $427000.0 in 2025, then plunged by 30.44% to $297000.0 in 2026.
- The last three Interest & Investment Income figures came in at $297000.0 (Q1 2026), $427000.0 (Q4 2025), and $554000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 297,000.00 |
| Dec 31, 2025 | 427,000.00 |
| Sep 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 192,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Sep 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |